Merit’s long-time executive, Joe Wright, has been appointed to the new role of Chief Commercial Officer and will be responsible for leading all commercial activities for the global organization. SOUTH JORDAN, Utah, Nov. 01, 2022 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer […]
Tag: Merit Medical
Merit Medical Reports Results for Quarter Ended September 30, 2022
Q3 2022 reported revenue of $287.2 million, up 7.5% compared to Q3 2021 Q3 2022 constant currency revenue, organic* up 10.5% compared to Q3 2021 Q3 2022 GAAP operating margin of 6.5%, compared to 6.0% in Q3 2021 Q3 2022 non-GAAP operating margin* of 16.1%, compared to 14.8% in Q3 […]
Merit Medical Launches the Prelude Roadster™ Guide Sheath
New long guide sheath accesses difficult anatomy in the peripheral vasculature, expanding treatment to more patients SOUTH JORDAN, Utah, Sept. 12, 2022 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced U.S. commercial release of the Prelude Roadster™ Guide […]
Merit Medical Launches SafeGuard Focus Cool™ Compression Device
Modern design advances patient care by combining hemostasis with innovative cooling capability SOUTH JORDAN, Utah, Aug. 08, 2022 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the launch of its SafeGuard Focus Cool™ Compression Device, an innovative addition […]
Merit Medical Reports Results for Quarter Ended June 30, 2022
Q2 2022 reported revenue of $295.0 million, up 5.2% compared to Q2 2021 Q2 2022 constant currency revenue, organic* up 7.4% compared to Q2 2021 Q2 2022 GAAP operating margin of 7.9%, compared to 3.2% in Q2 2021 Q2 2022 non-GAAP operating margin of 19.1%, compared to 16.3% in Q2 […]
First Patient Enrolled in Merit Medical’s WRAPSODY™ Registry (WRAP) Study
Prospective, international, multicenter, observational study to assess the real-world safety and efficacy of the WRAPSODY Cell-Impermeable Endoprosthesis SOUTH JORDAN, Utah, July 05, 2022 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today the successful enrollment of the first patient […]
Merit Medical’s Chief Legal Officer and Corporate Secretary, Brian Lloyd, Receives Corporate Counsel Award from Utah Business Magazine
SOUTH JORDAN, Utah, April 21, 2022 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, is proud to announce that Brian G. Lloyd, Merit’s Chief Legal Officer and Corporate Secretary, is a recipient of Utah Business Magazine’s Corporate Counsel Award. The award recognizes exceptional […]
Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2021, Issues FY 2022 Guidance
Q4 2021 reported revenue of $278.5 million, up 7.9% on a reported basis and up 8.4% on a constant currency revenue, organic* basis, compared to Q4 2020 Q4 2021 GAAP EPS increased 32% year-over-year to $0.36, compared to $0.27 in Q4 2020 Q4 2021 non-GAAP EPS* increased 31% year-over-year to […]
Merit Medical Reports Results For Quarter Ended September 30, 2021
Q3 2021 reported revenue of $267.0 million, up 9.4% compared to Q3 2020 Q3 2021 constant currency revenue, organic* up 8.8% compared to Q3 2020 Q3 2021 GAAP EPS of $0.21, compared to GAAP loss per share of ($0.05) in Q3 2020 Q3 2021 non-GAAP EPS* of $0.52, compared to […]
Merit Medical Announces Positive Results in First-in-Human Study of WRAPSODY™ Cell-Impermeable Endoprosthesis
Prospective, observational study published in CardioVascular and Interventional Radiology1 reports 100% target lesion primary patency (“TLPP”) rate without reintervention through 30 days, with a 12-month TLPP rate of 84.6% and a 12-month access circuit primary patency (“ACPP”) rate of 65.9%. Authors conclude the results suggest WRAPSODY Endoprosthesis is a safe and […]